Published June 27, 2019
| Version v1
Patent
Open
TREATMENT OF TNF- alpha CYTOTOXICITY
Contributors
Patent applicant:
Description
Provided herein is technology relating to treating and/or ameliorating TNFα cytotoxicity and particularly, but not exclusively, to compositions, methods, and kits for specifically modulating BCL-2-associated death promoter (BAD) activity, for example, by modulating the activity of Src and/or p190GAP.
Files
US20190192484.pdf
Files
(3.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:85291f55d2c645b4113a1802b2af4e88
|
3.7 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201716329499 A
- Patent number
- US 2019/0192484 A1
- Other
- oai:uchicago.tind.io:8137
Dates
- Patent filed
-
2017-09-01